Zhenxing Biopharmaceutical and Chemical Co., Ltd. Fundamental Rankings
This page is comprehensive fundamental data for Zhenxing Biopharmaceutical and Chemical Co., Ltd.. Fundamentals are ordered by how Zhenxing Biopharmaceutical and Chemical Co., Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.
Cite in Wikipedia:
| Indicator | Value | n/price | Rank | Date | Historic |
|---|---|---|---|---|---|
| Interests payable | 210,392,075 | 0.03944 | 9 | 2015-06-30 | historic |
| Estimated liabilities | 30,732,871 | 0.00576 | 74 | 2015-06-30 | historic |
| Payroll payable | 26,188,770 | 0.00491 | 361 | 2015-06-30 | historic |
| Financial expenses | 16,281,826 | 0.00305 | 450 | 2015-06-30 | historic |
| Other payables | 83,161,561 | 0.01559 | 456 | 2015-06-30 | historic |
| Other receivables | 38,479,895 | 0.00721 | 474 | 2015-06-30 | historic |
| Long term borrowings | 62,000,000 | 0.01162 | 505 | 2015-06-30 | historic |
| Operating profit | 63,129,725 | 0.01183 | 513 | 2015-06-30 | historic |
| Net cash flows from investing activities | -28,585,795 | -0.00536 | 518 | 2015-06-30 | historic |
| Fixed assets | 602,864,828 | 0.11302 | 522 | 2015-06-30 | historic |
| Net change in cash | 20,697,684 | 0.00388 | 550 | 2015-06-30 | historic |
| Total profit | 63,092,661 | 0.01183 | 565 | 2015-06-30 | historic |
| Net income | 49,542,899 | 0.00929 | 585 | 2015-06-30 | historic |
| Total comprehensive income | 49,542,899 | 0.00929 | 597 | 2015-06-30 | historic |
| Minority interest | 31,815,034 | 0.00596 | 616 | 2015-06-30 | historic |
| Short term borrowings | 184,950,000 | 0.03467 | 643 | 2015-06-30 | historic |
| Inventories | 258,725,931 | 0.0485 | 684 | 2015-06-30 | historic |
| Cash paid for taxes | 37,474,795 | 0.00703 | 701 | 2015-06-30 | historic |
| Purchases of fixed assets and others | 28,585,795 | 0.00536 | 736 | 2015-06-30 | historic |
| Total non-current assets | 843,674,990 | 0.15816 | 742 | 2015-06-30 | historic |
| Intangible assets | 68,440,735 | 0.01283 | 754 | 2015-06-30 | historic |
| Total liabilities | 726,649,092 | 0.13622 | 778 | 2015-06-30 | historic |
| Diluted eps | 0 | 0.0 | 830 | 2015-06-30 | historic |
| Deferred tax assets | 6,697,301 | 0.00126 | 850 | 2015-06-30 | historic |
| Net cashflow from financing activities | -18,689,756 | -0.0035 | 890 | 2015-06-30 | historic |
| Comprehensive income attributable to minority shareholders | -3,941,434 | -7.4E-4 | 1007 | 2015-06-30 | historic |
| Cash inflows from operating activities | 275,805,499 | 0.0517 | 1015 | 2015-06-30 | historic |
| Minority interests gain | -3,941,434 | -7.4E-4 | 1020 | 2015-06-30 | historic |
| Revenue | 255,272,381 | 0.04785 | 1038 | 2015-06-30 | historic |
| Total cost of goods sold | 192,142,657 | 0.03602 | 1079 | 2015-06-30 | historic |
| Total liabilities and equity | 1,234,841,913 | 0.23149 | 1082 | 2015-06-30 | historic |
| Other current assets | 12,936 | 0.0 | 1116 | 2015-06-30 | historic |
| Prepayment | 8,724,451 | 0.00164 | 1118 | 2015-06-30 | historic |
| Non-operating loss | 37,671 | 1.0E-5 | 1122 | 2015-06-30 | historic |
| Cash outflows from operating activities | 207,832,264 | 0.03896 | 1134 | 2015-06-30 | historic |
| Accounts payable | 35,972,559 | 0.00674 | 1153 | 2015-06-30 | historic |
| Cash paid for dividends, profits or interests | 4,689,756 | 8.8E-4 | 1165 | 2015-06-30 | historic |
| Capital reserve | 113,930,562 | 0.02136 | 1166 | 2015-06-30 | historic |
| Selling expenses | 3,353,872 | 6.3E-4 | 1192 | 2015-06-30 | historic |
| Net cash and cash equivalents ending balance | 64,394,749 | 0.01207 | 1235 | 2015-06-30 | historic |